Dexcom, a medtech device company best known for its continuous glucose monitoring systems, is launching a new venture fund aimed at investing in adjacent businesses.
Called Dexcom Ventures, the new investor will be zeroing in on sensing technology, data analytics, remote patient monitoring and population health. In fact, the new venture is expected to fund companies working in glucose sensing...